Biotech News

LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026

LeMaitre Vascular (LMAT)LeMaitre VascularEarnings

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here . All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com .

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

Related news

LeMaitre Vascular

Vascular Device Company LeMaitre Vascular develops devices, implants, and services used by vascular surgeons to treat peripheral vascular disease. Its portfolio is focused on open surgical and endovascular procedures outside the heart. Grafts and Biological Implants The company offers synthetic vascular grafts, Artegraft biological...

Recent company news

Stock data

Close
79.05 USD
Market cap
2.09B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States